Endogenous circadian regulation of pro-inflammatory cytokines and chemokines in the presence of bacterial lipopolysaccharide in humans

Brain, Behavior, and Immunity

Volumn 47, Issue , 2015, Pages 4-13

  Rahman, Shadab A ^a,b   Castanon Cervantes, Oscar ^c   Scheer, Frank A J L ^a,b   Shea, Steven A ^a,b,d   Czeisler, Charles A ^a,b   Davidson, Alec J ^c   Lockley, Steven W ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chemokine; Circadian; Cytokine; Human; Immune response; Lipopolysaccharide; Melatonin; Sleep

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHEMOKINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR;

ADULT; ADVERSE DRUG REACTION; ARTICLE; BEHAVIOR; CIRCADIAN RHYTHM; ENVIRONMENTAL FACTOR; EVOKED RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MALE; NEUROBIOLOGY; NIGHT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SLEEP WAKING CYCLE; BLOOD; DRUG EFFECTS; PHYSIOLOGY; YOUNG ADULT;

ADULT; CHEMOKINE CCL2; CIRCADIAN RHYTHM; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84930763599     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.11.003     Document Type: Article

References (54)

1. Abo T., Kawate T., Itoh K., Kumagai K. Studies on the bioperiodicity of the immune response. I. Circadian rhythms of human T, B, and K cell traffic in the peripheral blood. J. Immunol. 1981, 126:1360-1363.
2. Adams K.L., Castanon-Cervantes O., Evans J.A., Davidson A.J. Environmental circadian disruption elevates the IL-6 response to lipopolysaccharide in blood. J. Biol. Rhythms 2013, 28:272-277.
3. Boivin D.B., James F.O., Wu A., Cho-Park P.F., Xiong H., Sun Z.S. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 2003, 102:4143-4145.
4. Born J., Lange T., Hansen K., Molle M., Fehm H.L. Effects of sleep and circadian rhythm on human circulating immune cells. J. Immunol. 1997, 158:4454-4464.
5. Brager A.J., Ehlen J.C., Castanon-Cervantes O., Natarajan D., Delisser P., Davidson A.J., Paul K.N. Sleep loss and the inflammatory response in mice under chronic environmental circadian disruption. PLoS ONE 2013, 8:e63752.
6. Brown E.N., Czeisler C.A. The statistical analysis of circadian phase and amplitude in constant-routine core-temperature data. J. Biol. Rhythms 1992, 7:177-202.
7. Castanon-Cervantes O., Wu M., Ehlen J.C., Paul K., Gamble K.L., Johnson R.L., Besing R.C., Menaker M., Gewirtz A.T., Davidson A.J. Dysregulation of inflammatory responses by chronic circadian disruption. J. Immunol. 2010, 185:5796-5805.
8. Cechin S.R., Buchwald P. Effects of representative glucocorticoids on TNFalpha- and CD40L-induced NF-kappaB activation in sensor cells. Steroids 2014, 85:36-43.
9. Chua E.C., Shui G., Lee I.T., Lau P., Tan L.C., Yeo S.C., Lam B.D., Bulchand S., Summers S.A., Puvanendran K., Rozen S.G., Wenk M.R., Gooley J.J. Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:14468-14473.
10. Cutolo M. Chronobiology and the treatment of rheumatoid arthritis. Curr. Opin. Rheumatol. 2012, 24:312-318.
11. Czeisler C.A., Klerman E.B. Circadian and sleep-dependent regulation of hormone release in humans. Recent Prog. Horm. Res. 1999, 54:97-132.
12. De Groote D., Zangerle P.F., Gevaert Y., Fassotte M.F., Beguin Y., Noizat-Pirenne F., Pirenne J., Gathy R., Lopez M., Dehart I., et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992, 4:239-248.
13. Dinges D.F., Douglas S.D., Zaugg L., Campbell D.E., McMann J.M., Whitehouse W.G., Orne E.C., Kapoor S.C., Icaza E., Orne M.T. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64h of sleep deprivation. J. Clin. Invest. 1994, 93:1930-1939.
14. Dixit V.D., Yang H., Sayeed K.S., Stote K.S., Rumpler W.V., Baer D.J., Longo D.L., Mattson M.P., Taub D.D. Controlled meal frequency without caloric restriction alters peripheral blood mononuclear cell cytokine production. J. Inflamm. (Lond.) 2011, 8:6.
15. Duffy J.F., Dijk D.J. Getting through to circadian oscillators: why use constant routines?. J. Biol. Rhythms 2002, 17:4-13.
16. Engstad C.S., Gutteberg T.J., Osterud B. Modulation of blood cell activation by four commonly used anticoagulants. Thromb. Haemost. 1997, 77:690-696.
17. Esquifino A.I., Selgas L., Arce A., Maggiore V.D., Cardinali D.P. Twenty-four-hour rhythms in immune responses in rat submaxillary lymph nodes and spleen: effect of cyclosporine. Brain Behav. Immun. 1996, 10:92-102.
18. Fortier E.E., Rooney J., Dardente H., Hardy M.P., Labrecque N., Cermakian N. Circadian variation of the response of T cells to antigen. J. Immunol. 2011, 187:6291-6300.
19. Gibbs J.E., Blaikley J., Beesley S., Matthews L., Simpson K.D., Boyce S.H., Farrow S.N., Else K.J., Singh D., Ray D.W., Loudon A.S. The nuclear receptor REV-ERBalpha mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:582-587.
20. Gooley J.J., Rajaratnam S.M.W., Brainard G.C., Kronauer R.E., Czeisler C.A., Lockley S.W. Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light. Sci. Transl. Med. 2010, 2:31ra33.
21. Haack M., Reichenberg A., Kraus T., Schuld A., Yirmiya R., Pollmacher T. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men. Cytokine 2000, 12:694-698.
22. Haack M., Kraus T., Schuld A., Dalal M., Koethe D., Pollmacher T. Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures. Psychoneuroendocrinology 2002, 27:921-931.
23. Halberg F., Johnson E.A., Brown B.W., Bittner J.J. Susceptibility rhythm to E. coli endotoxin and bioassay. Proc. Soc. Exp. Biol. Med. 1960, 103:142-144.
24. Hayashi M., Shimba S., Tezuka M. Characterization of the molecular clock in mouse peritoneal macrophages. Biol. Pharm. Bull. 2007, 30:621-626.
25. Hermann C., von Aulock S., Dehus O., Keller M., Okigami H., Gantner F., Wendel A., Hartung T. Endogenous cortisol determines the circadian rhythm of lipopolysaccharide - but not lipoteichoic acid - inducible cytokine release. Eur. J. Immunol. 2006, 36:371-379.
26. Hochart H., Jenkins P.V., Preston R.J., Smith O.P., White B., O'Donnell J. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood. Thromb. Haemost. 2008, 99:570-575.
27. Horne J.A., Östberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int. J. Chronobiol. 1976, 4:97-110.
28. James F.O., Cermakian N., Boivin D.B. Circadian rhythms of melatonin, cortisol, and clock gene expression during simulated night shift work. Sleep 2007, 30:1427-1436.
29. Kang Y.S., Lee M.H., Song H.K., Ko G.J., Kwon O.S., Lim T.K., Kim S.H., Han S.Y., Han K.H., Lee J.E., Han J.Y., Kim H.K., Cha D.R. CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice. Kidney Int. 2010, 78:883-894.
30. Kawate T., Abo T., Hinuma S., Kumagai K. Studies of the bioperiodicity of the immune response. II. Co-variations of murine T and B cells and a role of corticosteroid. J. Immunol. 1981, 126:1364-1367.
31. Keller M., Mazuch J., Abraham U., Eom G.D., Herzog E.D., Volk H.D., Kramer A., Maier B. A circadian clock in macrophages controls inflammatory immune responses. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21407-21412.
32. Litinski M., Scheer F.A., Shea S.A. Influence of the circadian system on disease severity. Sleep Med. Clin. 2009, 4:143-163.
33. Lockley S.W., Evans E.E., Scheer F.A.J.L., Brainard G.C., Czeisler C.A., Aeschbach D. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep 2006, 29:161-168.
34. Manning P.J., Sutherland W.H., McGrath M.M., de Jong S.A., Walker R.J., Williams M.J. Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity (Silver Spring) 2008, 16:2046-2052.
35. Mills J.N. Human circadian rhythms. Physiol. Rev. 1966, 46:128-171.
36. Mills J.N., Minors D.S., Waterhouse J.M. Adaptation to abrupt time shifts of the oscillator[s] controlling human circadian rhythms. J. Physiol. (London) 1978, 285:455-470.
37. Niu J., Kolattukudy P.E. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin. Sci. (Lond.) 2009, 117:95-109.
38. Palmblad J., Cantell K., Strander H., Froberg J., Karlsson C.G., Levi L., Granstrom M., Unger P. Stressor exposure and immunological response in man: interferon-producing capacity and phagocytosis. J. Psychosom. Res. 1976, 20:193-199.
39. Patil R., Shukre S., Paranjape R., Thakar M. Heparin and EDTA anticoagulants differentially affect the plasma cytokine levels in humans. Scand. J. Clin. Lab. Invest. 2013, 73:452-455.
40. Pittendrigh C.S. Circadian rhythms and the circadian organization of living systems. Cold Spring Harb. Symp. Quant. Biol. 1960, 25:159-184.
41. Puttonen S., Viitasalo K., Harma M. Effect of shiftwork on systemic markers of inflammation. Chronobiol. Int. 2011, 28:528-535.
42. Sato S., Sakurai T., Ogasawara J., Takahashi M., Izawa T., Imaizumi K., Taniguchi N., Ohno H., Kizaki T. A circadian clock gene, Rev-erbalpha, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression. J. Immunol. 2014, 192:407-417.
43. Scheer F.A., Hilton M.F., Mantzoros C.S., Shea S.A. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4453-4458.
44. Scheer F.A., Hu K., Evoniuk H., Kelly E.E., Malhotra A., Hilton M.F., Shea S.A. Impact of the human circadian system, exercise, and their interaction on cardiovascular function. Proc. Natl. Acad. Sci. U.S.A. 2010.
45. Seijkens T., Hoeksema M.A., Beckers L., Smeets E., Meiler S., Levels J., Tjwa M., de Winther M.P., Lutgens E. Hypercholesterolemia-induced priming of hematopoietic stem and progenitor cells aggravates atherosclerosis. Faseb J 2014, 28:2202-2213.
46. Seok S.J., Lee E.S., Kim G.T., Hyun M., Lee J.H., Chen S., Choi R., Kim H.M., Lee E.Y., Chung C.H. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Nephrol. Dial. Transplant. 2013, 28:1700-1710.
47. Shackelford P.G., Feigin R.D. Periodicity of susceptibility to pneumococcal infection: influence of light and adrenocortical secretions. Science 1973, 182:285-287.
48. Stone E.F., Fulton B.O., Ayres J.S., Pham L.N., Ziauddin J., Shirasu-Hiza M.M. The circadian clock protein timeless regulates phagocytosis of bacteria in Drosophila. PLoS Pathog. 2012, 8:e1002445.
49. Straub R.H., Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum. 2007, 56:399-408.
50. Vaughan G.M. New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response. J. Pineal Res. 1993, 15:88-103.
51. Vgontzas A.N., Zoumakis M., Bixler E.O., Lin H.M., Prolo P., Vela-Bueno A., Kales A., Chrousos G.P. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J. Clin. Endocrinol. Metab. 2003, 88:2087-2095.
52. Wang W., Barnaby J.Y., Tada Y., Li H., Tor M., Caldelari D., Lee D.U., Fu X.D., Dong X. Timing of plant immune responses by a central circadian regulator. Nature 2011, 470:110-114.
53. Wang X.S., Armstrong M.E., Cairns B.J., Key T.J., Travis R.C. Shift work and chronic disease: the epidemiological evidence. Occup. Med. 2011, 61:78-89.
54. Young M.R., Matthews J.P., Kanabrocki E.L., Sothern R.B., Roitman-Johnson B., Scheving L.E. Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor in men. Chronobiol. Int. 1995, 12:19-27.